Connect with us

Life Sciences

Innovative automated algorithm improves detection of neuronal fitness in synucleinopathy

Oak Brook, IL – The April 2023 issue of SLAS Technology contains four original research articles and one technical brief covering the development of…

Published

on

This article was originally published by BioEngineering

Oak Brook, IL – The April 2023 issue of SLAS Technology contains four original research articles and one technical brief covering the development of robotic systems, ultrasound frequency sonification, automated algorithm development and other laboratory automation technology.

Development of algorithms for automated analysis of neuronal survival assay using BioStation CT and CL-Quant.

Credit: Jeonghoon Choi, et al.

Oak Brook, IL – The April 2023 issue of SLAS Technology contains four original research articles and one technical brief covering the development of robotic systems, ultrasound frequency sonification, automated algorithm development and other laboratory automation technology.

Featured in this issue is the article “Automated algorithm development to assess survival of human neurons using longitudinal single-cell tracking: Application to synucleinopathy,” by Choi, et al, which focuses on the use of longitudinal single-cell tracking to evaluate induced pluripotent stem cell (iPSC)-derived human neurons to study Parkinson’s disease, dementia with Lewy bodies and other synucleinopathies.

Previous drug discovery assays in this area have required manual cell counting to track cell death and markers of neuronal fitness, which are historically time-consuming, tedious and prone to error. To overcome these challenges, the researchers developed an algorithm capable of measuring these parameters with accuracy comparable to manual counting with better consistency, demonstrated through an evaluation of the neuroprotective effects of brain-derived neurotrophic factor (BDNF) on neurons overexpressing -synuclein (A53T).

Access the April issue of SLAS Technology to learn more about the future applications of this automated algorithm and other laboratory automation technology research articles.

The April issue of SLAS Technology includes these additional articles:

  • Automation of yeast spot assays using an affordable liquid handling robot
  • Automated algorithm development to assess survival of human neurons using longitudinal single-cell tracking: Application to synucleinopathy
  • Ultrasound frequency sonication facilitates high-throughput and uniform dissociation of cellular aggregates and tissues
  • Towards robotic laboratory automation plug & play: Survey and concept proposal on teaching-free robot integration with the LAPP digital twin
  • Development of a novel, automated, robotic system for rapid, high-throughput, parallel, solid-phase peptide synthesis
  • Life sciences discovery and technology highlights
     

Access to the April issue of SLAS Technology is available at https://slas-technology.org/issue/S2472-6303(23)X0003-X

*****

SLAS Technology reveals how scientists adapt technological advancements for life sciences exploration and experimentation in biomedical research and development. The journal emphasizes scientific and technical advances that enable and improve:

  • Life sciences research and development
  • Drug delivery
  • Diagnostics
  • Biomedical and molecular imaging
  • Personalized and precision medicine

SLAS (Society for Laboratory Automation and Screening) is an international professional society of academic, industry and government life sciences researchers and the developers and providers of laboratory automation technology. The SLAS mission is to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global community building.

SLAS Technology: Translating Life Sciences Innovation, 2021 Impact Factor 2.813. Editor-in-Chief Edward Kai-Hua Chow, Ph.D., National University of Singapore (Singapore).

 

###



drug delivery
life sciences

Markets

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending